Pfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential Carcinogen
FRIDAY, Sept. 17, 2021 (HealthDay News) — Pfizer is expanding the recall of its anti-smoking drug Chantix (varenicline), the company announced Friday. The nationwide recall of all Chantix 0.5 mg and 1 mg tablets was prompted because they may contain levels of a nitrosamine, N-nitroso-varenicline, that are at or aboveContinue Reading